blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2646606

EP2646606 - SURFACE-ANCHORED FC-BAIT ANTIBODY DISPLAY SYSTEM [Right-click to bookmark this link]
Former [2013/41]SURFACE, ANCHORED FC-BAIT ANTIBODY DISPLAY SYSTEM
[2018/21]
StatusNo opposition filed within time limit
Status updated on  16.08.2019
Database last updated on 20.09.2024
FormerThe patent has been granted
Status updated on  07.09.2018
FormerGrant of patent is intended
Status updated on  30.04.2018
FormerExamination is in progress
Status updated on  01.06.2017
Most recent event   Tooltip03.07.2020Lapse of the patent in a contracting state
New state(s): CY, MK
published on 05.08.2020  [2020/32]
Applicant(s)For all designated states
Merck Sharp & Dohme Corp.
126 East Lincoln Road
Rahway, New Jersey 07065-0907 / US
[2018/41]
Former [2013/41]For all designated states
Merck Sharp&Dohme Corp.
126 East Lincoln Road
Rahway, New Jersey 07106 / US
Inventor(s)01 / ZHA, Dongxing
21 Lafayette Street
Suite 200
Lebanon New Hampshire 03766 / US
02 / SHAHEEN, Hussam Hisham
21 Lafayette Street
Suite 200
Lebanon New Hampshire 03766 / US
 [2013/41]
Representative(s)Horgan, James Michael Frederic
Merck Sharp & Dohme (UK) Limited
120 Moorgate
London EC2M 6UR / GB
[N/P]
Former [2013/41]Horgan, James Michael Frederic
Merck & Co., Inc.
European Patent Department
Hertford Road
Hoddesdon
Hertfordshire EN11 9BU / GB
Application number, filing date11844912.329.11.2011
[2018/41]
WO2011US62286
Priority number, dateUS20100458771P01.12.2010         Original published format: US 458771 P
[2013/41]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2012074948
Date:07.06.2012
Language:EN
[2012/23]
Type: A2 Application without search report 
No.:EP2646606
Date:09.10.2013
Language:EN
The application published by WIPO in one of the EPO official languages on 07.06.2012 takes the place of the publication of the European patent application.
[2013/41]
Type: B1 Patent specification 
No.:EP2646606
Date:10.10.2018
Language:EN
[2018/41]
Search report(s)International search report - published on:US19.07.2012
(Supplementary) European search report - dispatched on:EP22.04.2014
ClassificationIPC:C40B40/02, C07K16/00, C07K16/32, C07K16/40, C07K16/46, C12N15/10, C40B40/10
[2018/18]
CPC:
C12N15/1037 (EP,CN,US); C07K16/46 (CN,US); C07K16/00 (EP,CN,US);
C07K16/32 (EP,CN,US); C07K16/40 (EP,CN,US); C40B40/10 (EP,CN,US);
C07K2317/14 (EP,CN,US); C07K2317/21 (EP,CN,US); C07K2317/35 (EP,CN,US);
C07K2317/41 (EP,CN,US); C07K2317/52 (EP,CN,US) (-)
Former IPC [2014/19]C40B40/02, C07K16/00
Former IPC [2013/41]C40B40/02
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2013/41]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:OBERFLÄCHEN-VERANKERTES FC-BEUTE-ANTIKÖRPERANZEIGESYSTEM[2018/21]
English:SURFACE-ANCHORED FC-BAIT ANTIBODY DISPLAY SYSTEM[2018/21]
French:SYSTÈME DE PRÉSENTATION D'ANTICORPS FC-LEURRE ANCRÉ EN SURFACE[2013/41]
Former [2013/41]OBERFLÄCHE UND VERANKERTES FC-BEUTE-ANTIKÖRPERANZEIGESYSTEM
Former [2013/41]SURFACE, ANCHORED FC-BAIT ANTIBODY DISPLAY SYSTEM
Entry into regional phase01.07.2013National basic fee paid 
01.07.2013Search fee paid 
01.07.2013Designation fee(s) paid 
01.07.2013Examination fee paid 
Examination procedure01.07.2013Examination requested  [2013/41]
13.11.2014Amendment by applicant (claims and/or description)
01.04.2016Despatch of a communication from the examining division (Time limit: M06)
10.10.2016Reply to a communication from the examining division
22.05.2017Despatch of a communication from the examining division (Time limit: M06)
30.11.2017Reply to a communication from the examining division
30.04.2018Communication of intention to grant the patent
31.08.2018Fee for grant paid
31.08.2018Fee for publishing/printing paid
31.08.2018Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  01.04.2016
Opposition(s)11.07.2019No opposition filed within time limit [2019/38]
Fees paidRenewal fee
07.11.2013Renewal fee patent year 03
07.11.2014Renewal fee patent year 04
06.11.2015Renewal fee patent year 05
07.11.2016Renewal fee patent year 06
08.11.2017Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU29.11.2011
AL10.10.2018
AT10.10.2018
CY10.10.2018
CZ10.10.2018
DK10.10.2018
EE10.10.2018
ES10.10.2018
FI10.10.2018
HR10.10.2018
IT10.10.2018
LT10.10.2018
LV10.10.2018
MC10.10.2018
MK10.10.2018
NL10.10.2018
PL10.10.2018
RO10.10.2018
RS10.10.2018
SE10.10.2018
SI10.10.2018
SK10.10.2018
SM10.10.2018
TR10.10.2018
IE29.11.2018
LU29.11.2018
MT29.11.2018
BE30.11.2018
CH30.11.2018
LI30.11.2018
BG10.01.2019
NO10.01.2019
GR11.01.2019
IS10.02.2019
PT10.02.2019
[2020/31]
Former [2020/30]HU29.11.2011
AL10.10.2018
AT10.10.2018
CZ10.10.2018
DK10.10.2018
EE10.10.2018
ES10.10.2018
FI10.10.2018
HR10.10.2018
IT10.10.2018
LT10.10.2018
LV10.10.2018
MC10.10.2018
NL10.10.2018
PL10.10.2018
RO10.10.2018
RS10.10.2018
SE10.10.2018
SI10.10.2018
SK10.10.2018
SM10.10.2018
TR10.10.2018
IE29.11.2018
LU29.11.2018
MT29.11.2018
BE30.11.2018
CH30.11.2018
LI30.11.2018
BG10.01.2019
NO10.01.2019
GR11.01.2019
IS10.02.2019
PT10.02.2019
Former [2020/17]AL10.10.2018
AT10.10.2018
CZ10.10.2018
DK10.10.2018
EE10.10.2018
ES10.10.2018
FI10.10.2018
HR10.10.2018
IT10.10.2018
LT10.10.2018
LV10.10.2018
MC10.10.2018
NL10.10.2018
PL10.10.2018
RO10.10.2018
RS10.10.2018
SE10.10.2018
SI10.10.2018
SK10.10.2018
SM10.10.2018
TR10.10.2018
IE29.11.2018
LU29.11.2018
MT29.11.2018
BE30.11.2018
CH30.11.2018
LI30.11.2018
BG10.01.2019
NO10.01.2019
GR11.01.2019
IS10.02.2019
PT10.02.2019
Former [2020/08]AL10.10.2018
AT10.10.2018
CZ10.10.2018
DK10.10.2018
EE10.10.2018
ES10.10.2018
FI10.10.2018
HR10.10.2018
IT10.10.2018
LT10.10.2018
LV10.10.2018
MC10.10.2018
NL10.10.2018
PL10.10.2018
RO10.10.2018
RS10.10.2018
SE10.10.2018
SI10.10.2018
SK10.10.2018
SM10.10.2018
IE29.11.2018
LU29.11.2018
MT29.11.2018
BE30.11.2018
CH30.11.2018
LI30.11.2018
BG10.01.2019
NO10.01.2019
GR11.01.2019
IS10.02.2019
PT10.02.2019
Former [2019/50]AL10.10.2018
AT10.10.2018
CZ10.10.2018
DK10.10.2018
EE10.10.2018
ES10.10.2018
FI10.10.2018
HR10.10.2018
IT10.10.2018
LT10.10.2018
LV10.10.2018
MC10.10.2018
NL10.10.2018
PL10.10.2018
RO10.10.2018
RS10.10.2018
SE10.10.2018
SI10.10.2018
SK10.10.2018
SM10.10.2018
IE29.11.2018
LU29.11.2018
BE30.11.2018
CH30.11.2018
LI30.11.2018
BG10.01.2019
NO10.01.2019
GR11.01.2019
IS10.02.2019
PT10.02.2019
Former [2019/48]AL10.10.2018
AT10.10.2018
CZ10.10.2018
DK10.10.2018
EE10.10.2018
ES10.10.2018
FI10.10.2018
HR10.10.2018
IT10.10.2018
LT10.10.2018
LV10.10.2018
MC10.10.2018
NL10.10.2018
PL10.10.2018
RO10.10.2018
RS10.10.2018
SE10.10.2018
SK10.10.2018
SM10.10.2018
IE29.11.2018
LU29.11.2018
CH30.11.2018
LI30.11.2018
BG10.01.2019
NO10.01.2019
GR11.01.2019
IS10.02.2019
PT10.02.2019
Former [2019/40]AL10.10.2018
AT10.10.2018
CZ10.10.2018
DK10.10.2018
EE10.10.2018
ES10.10.2018
FI10.10.2018
HR10.10.2018
IT10.10.2018
LT10.10.2018
LV10.10.2018
MC10.10.2018
NL10.10.2018
PL10.10.2018
RO10.10.2018
RS10.10.2018
SE10.10.2018
SK10.10.2018
SM10.10.2018
LU29.11.2018
CH30.11.2018
LI30.11.2018
BG10.01.2019
NO10.01.2019
GR11.01.2019
IS10.02.2019
PT10.02.2019
Former [2019/37]AL10.10.2018
AT10.10.2018
CZ10.10.2018
DK10.10.2018
EE10.10.2018
ES10.10.2018
FI10.10.2018
HR10.10.2018
IT10.10.2018
LT10.10.2018
LV10.10.2018
MC10.10.2018
NL10.10.2018
PL10.10.2018
RO10.10.2018
RS10.10.2018
SE10.10.2018
SM10.10.2018
LU29.11.2018
BG10.01.2019
NO10.01.2019
GR11.01.2019
IS10.02.2019
PT10.02.2019
Former [2019/35]AL10.10.2018
AT10.10.2018
CZ10.10.2018
DK10.10.2018
ES10.10.2018
FI10.10.2018
HR10.10.2018
IT10.10.2018
LT10.10.2018
LV10.10.2018
NL10.10.2018
PL10.10.2018
RS10.10.2018
SE10.10.2018
LU29.11.2018
BG10.01.2019
NO10.01.2019
GR11.01.2019
IS10.02.2019
PT10.02.2019
Former [2019/34]AL10.10.2018
AT10.10.2018
DK10.10.2018
ES10.10.2018
FI10.10.2018
HR10.10.2018
IT10.10.2018
LT10.10.2018
LV10.10.2018
NL10.10.2018
PL10.10.2018
RS10.10.2018
SE10.10.2018
LU29.11.2018
BG10.01.2019
NO10.01.2019
GR11.01.2019
IS10.02.2019
PT10.02.2019
Former [2019/26]AL10.10.2018
AT10.10.2018
ES10.10.2018
FI10.10.2018
HR10.10.2018
LT10.10.2018
LV10.10.2018
NL10.10.2018
PL10.10.2018
RS10.10.2018
SE10.10.2018
BG10.01.2019
NO10.01.2019
GR11.01.2019
IS10.02.2019
PT10.02.2019
Former [2019/25]AT10.10.2018
ES10.10.2018
FI10.10.2018
HR10.10.2018
LT10.10.2018
LV10.10.2018
NL10.10.2018
PL10.10.2018
RS10.10.2018
SE10.10.2018
BG10.01.2019
NO10.01.2019
GR11.01.2019
IS10.02.2019
Former [2019/24]AT10.10.2018
ES10.10.2018
FI10.10.2018
HR10.10.2018
LT10.10.2018
LV10.10.2018
NL10.10.2018
PL10.10.2018
SE10.10.2018
BG10.01.2019
NO10.01.2019
GR11.01.2019
IS10.02.2019
Former [2019/23]AT10.10.2018
ES10.10.2018
FI10.10.2018
HR10.10.2018
LT10.10.2018
LV10.10.2018
NL10.10.2018
PL10.10.2018
BG10.01.2019
NO10.01.2019
IS10.02.2019
Former [2019/22]FI10.10.2018
LT10.10.2018
NL10.10.2018
PL10.10.2018
BG10.01.2019
NO10.01.2019
IS10.02.2019
Former [2019/21]FI10.10.2018
LT10.10.2018
NL10.10.2018
NO10.01.2019
IS10.02.2019
Former [2019/20]LT10.10.2018
NL10.10.2018
NO10.01.2019
Former [2019/17]NL10.10.2018
Documents cited:Search[A]WO2008100816  (MEDIMMUNE INC [US], et al) [A] 1-24 * the whole document * * paragraph [0005]; figure 1 *;
 [I]US2009163379  (WANG KEVIN CAILI [US], et al) [I] 1-24 * paragraph [0009] * * paragraph [0011] * * paragraphs [0014] , [0016] * * paragraphs [0048] , [0065] * * paragraph [0053] * * paragraphs [0057] , [0070] * * paragraph [0085] *;
 [I]WO2009111183  (GLYCOFI INC [US], et al) [I] 1-24 * page 5, lines 8-10 * * page 5, lines 16-18 * * page 25, lines 5-36 * * page 26, lines 1-3 * * page 6, lines 17-24 *;
 [XPI]WO2011100566  (ONCOMED PHARM INC [US], et al) [XP] 1-6,8-15 * paragraph [0007] * [I] 7,16-24;
 [T]  - HUSSAM H. SHAHEEN ET AL, "A Dual-Mode Surface Display System for the Maturation and Production of Monoclonal Antibodies in Glyco-Engineered Pichia pastoris", PLOS ONE, (20130710), vol. 8, no. 7, doi:10.1371/journal.pone.0070190, page e70190, XP055109734 [T] 1-24 * the whole document *

DOI:   http://dx.doi.org/10.1371/journal.pone.0070190
International search[A]EP1743938  (NASCACELL IP GMBH [DE]);
 [Y]US2007105199  (YAN WEI [US], et al);
 [X]US2010009866  (PRINZ BIANKA [US], et al);
 [A]US2010075326  (JIN MOONSOO M [US], et al);
 [XP]US2010331192  (ZHA DONGXING [US], et al)
by applicantUS4816397
 US4952496
 US5168062
 US5225539
 US5385839
 US5530101
 US5693489
 US5869320
 US7029872
 US2006211085
 US7198921
 WO2007061631
 US7259007
 US2009163379
 WO2009111183
    - D.N. Glover, DNA Cloning: A Practical Approach, (19850000), vol. I and II
    - BENOIST et al., Nature, (19810000), vol. 290, pages 304 - 310
    - YAMAMOTO et al., Cell, (19800000), vol. 22, pages 787 - 797
    - WAGNER et al., Proc. Natl. Acad. Sci. USA, (19810000), vol. 78, pages 1441 - 1445
    - BRINSTER et al., Nature, (19820000), vol. 296, pages 39 - 42
    - VILLA-KOMAROFF et al., Proc. Natl. Acad. Sci. USA, (19780000), vol. 75, pages 3727 - 3731
    - DEBOER et al., Proc. Natl. Acad. Sci. USA, (19830000), vol. 80, pages 21 - 25
    - Scientific American, (19800000), vol. 242, pages 74 - 94
    - PHILLIPS et al., J. Bacteriol., (19840000), vol. 159, page 283
    - LEAHY et al., Science, (19920000), vol. 258, page 987
    - DAVANLOO, P. et al., Proc. Natl. Acad. Sci. USA, (19840000), vol. 81, pages 2035 - 2039
    - STUDIER, F. W. et al., J. Mol. Biol., (19860000), vol. 189, pages 113 - 130
    - ROSENBERG, A. H. et al., Gene, (19870000), vol. 56, pages 125 - 135
    - DUNN, J. J. et al., Gene, (19880000), vol. 68, page 259
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.